Clinical Trial Update: Tranexamic Acid for the Control of Blood Loss at Elective Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on tranexamic acid for controlling blood loss during elective cesarean sections; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section Complications

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Aswan University Hospital | Conditions: Cesarean Section Complications | Phase 4 | Status: COMPLETED